Skip to main content
Journal ArticleOPEN ACCESS

Ofatumumab for Rituximab-Resistant Nephrotic Syndrome

  • Basu B
New England Journal of Medicine (2014) 370(13) 1268-1270
DOI: 10.1056/nejmc1308488
100Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Abstract

Cases of the steroid-resistant nephrotic syndrome that are resistant to rituximab can be difficult to treat. In this report, ofatumumab, an anti-CD20 monoclonal antibody, showed some benefit in fiv...

Cite

CITATION STYLE

APA

Basu, B. (2014). Ofatumumab for Rituximab-Resistant Nephrotic Syndrome. New England Journal of Medicine, 370(13), 1268–1270. https://doi.org/10.1056/nejmc1308488

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free